John A. Orwin
Net Worth
Last updated:
What is John A. Orwin net worth?
The estimated net worth of Mr. John A. Orwin is at least $4,354,712 as of 11 Apr 2024. He has earned $37,112 from insider trading and has received compensation worth at least $4,317,600 in Atreca, Inc..
What is the salary of John A. Orwin?
Mr. John A. Orwin salary is $863,520 per year as Pres, Chief Executive Officer & Director in Atreca, Inc..
How old is John A. Orwin?
Mr. John A. Orwin is 60 years old, born in 1965.
What stocks does John A. Orwin currently own?
As insider, Mr. John A. Orwin owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Atreca, Inc. (BCEL) | Pres, Chief Executive Officer & Director | 1 | $0 | $0 |
What does Atreca, Inc. do?
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-101 product candidate reacts in vitro with a majority of human ovarian, non-small cell lung, colorectal, and breast cancer samples from multiple patients. It also developing APN-122597, a receptor tyrosine kinase that target tumor tissues; and ATRC-501/MAM01, that targets the circumsporozoite protein of Plasmodium falciparum for the treatment of malaria. It has a collaboration and license agreement with Xencor, Inc. for research, development, and commercialization of novel CD3 bispecific antibodies in oncology; licensing agreement with the Bill & Melinda Gates Medical Research Institute for the development and commercialization of MAM01/ATRC-501 for the prevention of malaria. Atreca, Inc. was incorporated in 2010 and is based in San Carlos, California.
John A. Orwin insider trading
Atreca, Inc.
Mr. John A. Orwin has made only one insider trade between 2020-2024, according to the Form 4 filled with the SEC. He purchased 1 units of BCEL stock worth $0 on 11 Apr 2024.
As of 11 Apr 2024 he still owns at least 1 units of BCEL stock.
Atreca key executives
Atreca, Inc. executives and other stock owners filed with the SEC:
- Mr. Herbert C. Cross (53) Chief Financial Officer
- Mr. John A. Orwin (60) Pres, Chief Executive Officer & Director